Most recent

ANSI/AAMI/ISO 22442-3:2007 (R2016)

Medical devices utilizing animal tissues and their derivatives - Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents


Specifies requirements for the validation of the elimination and/or inactivation of viruses and TSE agents during the manufacture of medical devices (excluding in-vitro diagnostic medical devices) utilizing animal tissue or products derived from animal tissue, which are non-viable or have been rendered non-viable. Does not cover other transmissible and non-transmissible agents.


CONTENT PROVIDER
Association for the Advancement of Medical Instrumentation [aami]

Others Also Bought
Medical devices utilizing animal tissues and their derivatives - Part 1: Application of risk management.
Medical devices utilizing animal tissues and their derivatives - Part 2: Controls on sourcing, collection and ...
Cleanrooms and associated controlled environments - Part 4: Design, construction and start-up
Document History
Included in Packages
This standard is not included in any packages.
Amendments & Corrections
We have no amendments or corrections for this standard.